Cyclophosphamide monohydrate
Molecular Structure:
MDL:
MFCD00149395
Molecular Formula:
C7H15Cl2N2O2P·H2O
Molecular Weight:
279.10
Alias:
安道生,环磷氮芥,癌得星,N,N-双(β-氯乙基)-N',O-三次甲基磷二酰胺酸酯-水化合物
2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
Cytoxan
Product order:
Name |
Specifications |
Packing |
Price |
Delivery |
Cyclophosphamide monohydrate |
97.0%-103.0%(HPLC) |
1g(原装) |
RMB 1353 |
现货 |
Cyclophosphamide monohydrate |
97% |
1g |
RMB 233.2 |
Consulting service |
Cyclophosphamide monohydrate |
97% |
5g |
RMB 759 |
Consulting service |
Cyclophosphamide monohydrate |
97% |
25g |
RMB 2838 |
Consulting service |
Character:
白色结晶或结晶性粉末,微溶于水,微溶于醇、苯、乙二醇、四氯化碳、二氧六圜,几乎不溶于乙醚及丙酮,失去结晶水即液化,水溶液不稳定,无臭、味微苦。
沸点: 110℃
熔点:49-53℃
Quality Standard:
外观Appearance 白色至类白色结晶或结晶粉末
红外光谱鉴别Infrared spectrometry 符合
熔点Melting point 49°C - 53°C
纯度Purity ≥97.0% (Titrimetry)
水分Water 6 - 7 %
Storage:
储存温度 2-8°C
环磷酰胺是一种细胞毒性物,广泛地用于癌症化疗。它交联DNA,引起DNA链断裂,从而诱发突变。它的临床活性和醛脱氢酶(aldehyde dehydrogenase 1,ALDH1)活性的减少密切相关。
Related Products
- Cyclophosphamide monohydrate
- 4-Bromophenethylamine
- N-Isopropylacrylamide
- Tris(2-aminoethyl)amine
- 4-Chlorobenzylamine
- N-Hydroxyphthalimide
- L-Buthionine-sulfoximine
- Dicyandiamide
- 1,8-Naphthalimide
- Dichlormid
- N-(Methoxymethyl)-N-(trimethylsilylmethyl)benzylamine
- N-N-Dimethylacetamide
- 3-Bromo-2-methylaniline
- Tris(N,N-tetramethylene)phosphoric acid triamide
- [3S-(3α,4aβ,8aβ)]-N-(tert-Butyl)decahydro-3-isoquinolinecarboxamide
- 2,5-Diethoxyaniline
- 3,4-Dimethoxyphenethylamine
- Cinnamamide, Predominantly trans
- N-(2,4-Dimethylphenyl)-3-oxobutyramide
- 3-(Dibutylamino)propylamine
- 3-Ethylaniline
- 3,4,5-Trimethoxyaniline
- Triacetonediamine
- N-Iodosuccinimide
- 2-(p-Tolyl)ethylamine
- N,N,N',N'-Tetramethyl-1,3-propanediamine
- N-Methylformanilide
- 2-Chlorobenzylamine
- 2,6-Diisopropylaniline
- N,N-Diethylformamide
- Triethanolamine
- Formanilide
- Cyanoacetamide
- Ethanamine
- 2-ethylhexyloxypropylamine
- (S)-(-)-2-Methyl-2-propanesulfinamide
- Poly(propylene glycol) bis(2-aminopropyl ether)
- (R)-(+)-1-(2-Naphthyl)ethylamine
- N-(2-Chloroethyl)acetamide
- L-Glutamic acid γ-(β-naphthylamide)
- 3′-Amino-4′-chloroacetanilide
- 4-Isopropylaniline
- DL-1-Amino-2-propanol
- 4,4',4-Trimethyltriphenylamine
- 4-Hydroxydiphenylamine
- Salicylamide
- Bicalutamide (CDX)
- N-Methylformamide
- 2-Thiophenesulfonamide
- 4-Aminobenzamide
- N,N-Dimethylacrylamide
- Tridodecylamine
- 2-Iodoaniline
- 4,5-Dichlorothiophene-2-sulfonamide
- 5-Bromo-2-thiophenesulfonamide
- Sulfaguanidine
- 3,4,4'-Trichlorocarbanilide
- 2,6-Dichloroquinone-4-chloroimide
- (S)-1-(4-Chlorophenyl)ethylamine
- N,N'-Di-sec-butyl-p-phenylenediamine
- N,N-Diethyltrimethylsilylamine
- Ciclopirox
- N,N'-Diisopropylcarbodiimide
- N,N'-Bis(3-methylphenyl)-N,N'-bis(phenyl)benzidine
- N,N-Bis(3-aminopropyl)methylamine
- 3-Lauryloxypropyl-1-amine
- 2,2',5,5'-Tetrachlorobenzidine
- (S)-(+)-2-Amino-3-methylbutane
- 3-Dimethylaminophenol
- (S)-(+)-Tetrahydrofurfurylamine
- o-Acetoacetanisidide
- N,N,N,N-Tetrakis(2-Hydroxypropyl)ethylenediamine
- 4-Nitro-3-(trifluoromethyl)aniline
- 4-Hydroxyphenylacetamide
- 2,5-Dichlorothiophene-3-sulfonamide
- 2'-Methylacetoacetanilide
- 4-Fluorobenzamide
- N-Phenyldiethanolamine
- 1-Bromo-3,5-dimethyladamantane
- (R)-(+)-α-Methylbenzylamine